David A. Siegel Charles River Laboratories International, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 28,100 shares of CRL stock, worth $4.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,100
Previous 16,300
72.39%
Holding current value
$4.7 Million
Previous $3.21 Million
61.59%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$851 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$682 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$365 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$302 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.51B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...